Get the Stockscreener App
9.98
0.10%
-0.010
Apogee Acquisition Corp stock is traded at $9.98, with a volume of 4,259.
It is down -0.10% in the last 24 hours and up +0.00% over the past month.
Apogee Acquisition Corp is a blank check company.
See More
Previous Close:
$9.99
Open:
$10
24h Volume:
4,259
Relative Volume:
0.05
Market Cap:
$234.23M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$9.98
$10.00
1-Week Range:
$9.96
$10.00
52-Week Range:
$9.94
$10.00
Apogee Acquisition Corp Stock (AACP) Company Profile
Name
Apogee Acquisition Corp
Sector
Industry
Phone
771.210.4643
Address
2106 HOUSE AVE SUITE 375, CHEYENNE
Compare AACP vs LION, XXI, UMAC, DMII, BCSS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AACP
Apogee Acquisition Corp
|
9.98 | 234.47M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
15.21 | 4.50B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.74 | 1.91B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
22.57 | 1.19B | 17.25M | -5.64M | -40.16M | -0.3337 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.09 | 643.37M | 0 | 8.58M | -1.11M | 0.134 |
BCSS
Bain Capital Gss Investment Corp
|
10.27 | 596.26M | 0 | 8.29M | -686.50K | 0.142 |
Apogee Acquisition Corp Stock (AACP) Latest News
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition - Insider Monkey
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio - Investing News Network
Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger - Yahoo Finance
AbbVie sharpens immunology focus with $10.9 billion Apogee deal - 102.7 WBOW
AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition (NASDAQ:APGE) - Seeking Alpha
AbbVie to Acquire Apogee Therapeutics for $10.9B - Genetic Engineering and Biotechnology News
AbbVie Acquires Apogee Therapeutics in 10.9 Billion Dollar Deal - HarianBasis.co
Apogee Enterprises Acquires Kalwall Companies for 115 Million Dollars - HarianBasis.co
AbbVie acquires Apogee Therapeutics for $10.9 billion - qz.com
Apogee Enterprises (APOG) Makes a $115 Million Bet; Could This Acquisition Reshape Its Growth Story? - Insider Monkey
AbbVie Acquires Apogee Therapeutics for 10.9 Billion Dollars - HarianBasis.co
AbbVie Buys Apogee for $10.9 Billion to Acquire Inflammatory Disease Drug Pipeline - streamlinefeed.co.ke
AbbVie Bets Big on Respiratory Pipeline With Apogee Acquisition -- Company Talk - Moomoo
AbbVie to acquire Apogee Therapeutics (NASDAQ: APGE) in $10.9B cash deal - Stock Titan
AbbVie (ABBV) Stock Dips as $10.9B Apogee Therapeutics Acquisition Nears Completion - MEXC
AbbVie pays $10.9B for Apogee to expand immunology pipeline - Stock Titan
AbbVie (ABBV) Pursues $10.9B Apogee Acquisition: JPMorgan Calls It Strategic Win - parameter.io
‘A Solid Fit’: JPMorgan Backs AbbVie’s Potential $11B Apogee Acquisition - TipRanks
AbbVie-Apogee acquisition a ‘solid fit,’ JPMorgan says - Investing.com
AbbVie Closes In on 10.9 Billion Dollar Apogee Acquisition - HarianBasis.co
Apogee Acquisition (AACP) Stock Trends and Sentiment 2026 - MarketBeat
Apogee Acquisition Corp Statistics – BOATS:AACPU - TradingView
Top ARC Group Acquisition I (ARCL) Competitors 2026 - MarketBeat
AACP Technical Analysis & Stock Price Forecast - Intellectia AI
AACP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
AACP Forecast — Price Prediction for 2026. Should I Buy AACP? - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
AACP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Income Statement - Intellectia AI
AACP News & Events - Intellectia AI
Apogee Therapeutics (NASDAQ: APGE) investors back board, pay and auditor - Stock Titan
Top Apogee Acquisition (AACP) Competitors 2026 - MarketBeat
AACP Should I Buy - Intellectia AI
Apogee Acquisition Corp Revenue Breakdown – NASDAQ:AACPR - TradingView
Apogee Acquisition Corp Income Statement – BOATS:AACPR - TradingView
What is the current Price Target and Forecast for Apogee Acquisition Corp. (AACP) - Zacks Investment Research
Apogee Acquisition Corp Rights (AACPR) AI-Powered Stock Analysis - Meyka
Apogee Acquisition Corp Warrant (AACPW) AI-Powered Stock Analysis - Meyka
Why Is Apogee Acquisition Corp Rights (AACPR) Stock Down Today? - Meyka
Apogee Acquisition Corp Class A Ordinary Shares (AACP) Stock Overall Grade - Meyka
Return on equity % of Apogee Acquisition Corp – BOATS:AACPW - TradingView
AACPW | Apogee Acquisition Corp Warrant Institutional Ownership - Quiver Quantitative
Apogee Acquisition Corp. (AACP) Cash From Financing (TTM) - Zacks Investment Research
Apogee Acquisition (AACP) Stock Price, News & Analysis - MarketBeat
Apogee Acquisition Corp Statistics – BOATS:AACPW - TradingView
Top ACP Holdings Acquisition (ACGC) Competitors 2026 - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Apogee Acquisition (AACP) 10K Form and Latest SEC Filings 2026 - MarketBeat
Apogee Acquisition Corp. (AACP) - Zacks Investment Research
Non-operating income (total) of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Latest Apogee Acquisition Corp Class A Ordinary Shares Stock News & AACP Headlines - CoinCodex
Apogee Acquisition Corp Stock (AACP) Financials Data
There is no financial data for Apogee Acquisition Corp (AACP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.18%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):